Cargando…

High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes

INTRODUCTION: High mobility group box 1 (HMGB1) is released by necrotic cells or secreted in response to inflammatory stimuli. Extracellular HMGB1 may act as a pro-inflammatory cytokine in rheumatoid arthritis. We have recently reported that HMGB1 is released by osteoarthritic synoviocytes after act...

Descripción completa

Detalles Bibliográficos
Autores principales: García-Arnandis, Isabel, Guillén, Maria Isabel, Gomar, Francisco, Pelletier, Jean-Pierre, Martel-Pelletier, Johanne, Alcaraz, Maria José
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2010
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945068/
https://www.ncbi.nlm.nih.gov/pubmed/20799933
http://dx.doi.org/10.1186/ar3124
_version_ 1782187173686018048
author García-Arnandis, Isabel
Guillén, Maria Isabel
Gomar, Francisco
Pelletier, Jean-Pierre
Martel-Pelletier, Johanne
Alcaraz, Maria José
author_facet García-Arnandis, Isabel
Guillén, Maria Isabel
Gomar, Francisco
Pelletier, Jean-Pierre
Martel-Pelletier, Johanne
Alcaraz, Maria José
author_sort García-Arnandis, Isabel
collection PubMed
description INTRODUCTION: High mobility group box 1 (HMGB1) is released by necrotic cells or secreted in response to inflammatory stimuli. Extracellular HMGB1 may act as a pro-inflammatory cytokine in rheumatoid arthritis. We have recently reported that HMGB1 is released by osteoarthritic synoviocytes after activation with interleukin-1beta (IL-1β) The present study investigated the role of HMGB1 in synovial inflammation in osteoarthritis (OA). METHODS: HMGB1 was determined in human synovium using immunohistochemistry, comparing normal to OA. OA synoviocytes were incubated with HMGB1 at 15 or 25 ng/ml in the absence or presence of IL-1β (10 ng/ml). Gene expression was analyzed by quantitative PCR and protein expression by Western Blot and ELISA. Matrix metalloproteinase (MMP) activity was studied by fluorometric procedures and nuclear factor (NF)-κB activation by transient transfection with a NF-κB-luciferase plasmid. RESULTS: In the normal synovium, HMGB1 was found in the synovial lining cells, sublining cells, and in the vascular wall cells. The distribution of HMGB1 in OA synovium was similar but the number of HMGB1 positive cells was higher and HMGB1 was also present in infiltrated cells. In normal synovial membrane cells, HMGB1 was found mostly in the nuclei, whereas in OA, HMGB1 was generally found mostly in the cytoplasm. In OA synoviocytes, HMGB1 alone at concentrations of 15 or 25 ng/ml did not affect the production of IL-6, IL-8, CCL2, CCL20, MMP-1 or MMP-3, but in the presence of IL-1β, a significant potentiation of protein and mRNA expression, as well as MMP activity was observed. HMGB1 also enhanced the phosphorylated ERK1/2 and p38 levels, with a lower effect on phosphorylated Akt. In contrast, JNK1/2 phosphorylation was not affected. In addition, HMGB1 at 25 ng/ml significantly potentiated NF-κB activation in the presence of IL-1β. CONCLUSIONS: Our results indicate that HMGB1 is overexpressed in OA synovium and mostly present in extracellular form. In OA synoviocytes, HMGB1 cooperates with IL-1β to amplify the inflammatory response leading to the production of a number of cytokines, chemokines and MMPs. Our data support a pro-inflammatory role for this protein contributing to synovitis and articular destruction in OA.
format Text
id pubmed-2945068
institution National Center for Biotechnology Information
language English
publishDate 2010
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-29450682010-09-25 High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes García-Arnandis, Isabel Guillén, Maria Isabel Gomar, Francisco Pelletier, Jean-Pierre Martel-Pelletier, Johanne Alcaraz, Maria José Arthritis Res Ther Research Article INTRODUCTION: High mobility group box 1 (HMGB1) is released by necrotic cells or secreted in response to inflammatory stimuli. Extracellular HMGB1 may act as a pro-inflammatory cytokine in rheumatoid arthritis. We have recently reported that HMGB1 is released by osteoarthritic synoviocytes after activation with interleukin-1beta (IL-1β) The present study investigated the role of HMGB1 in synovial inflammation in osteoarthritis (OA). METHODS: HMGB1 was determined in human synovium using immunohistochemistry, comparing normal to OA. OA synoviocytes were incubated with HMGB1 at 15 or 25 ng/ml in the absence or presence of IL-1β (10 ng/ml). Gene expression was analyzed by quantitative PCR and protein expression by Western Blot and ELISA. Matrix metalloproteinase (MMP) activity was studied by fluorometric procedures and nuclear factor (NF)-κB activation by transient transfection with a NF-κB-luciferase plasmid. RESULTS: In the normal synovium, HMGB1 was found in the synovial lining cells, sublining cells, and in the vascular wall cells. The distribution of HMGB1 in OA synovium was similar but the number of HMGB1 positive cells was higher and HMGB1 was also present in infiltrated cells. In normal synovial membrane cells, HMGB1 was found mostly in the nuclei, whereas in OA, HMGB1 was generally found mostly in the cytoplasm. In OA synoviocytes, HMGB1 alone at concentrations of 15 or 25 ng/ml did not affect the production of IL-6, IL-8, CCL2, CCL20, MMP-1 or MMP-3, but in the presence of IL-1β, a significant potentiation of protein and mRNA expression, as well as MMP activity was observed. HMGB1 also enhanced the phosphorylated ERK1/2 and p38 levels, with a lower effect on phosphorylated Akt. In contrast, JNK1/2 phosphorylation was not affected. In addition, HMGB1 at 25 ng/ml significantly potentiated NF-κB activation in the presence of IL-1β. CONCLUSIONS: Our results indicate that HMGB1 is overexpressed in OA synovium and mostly present in extracellular form. In OA synoviocytes, HMGB1 cooperates with IL-1β to amplify the inflammatory response leading to the production of a number of cytokines, chemokines and MMPs. Our data support a pro-inflammatory role for this protein contributing to synovitis and articular destruction in OA. BioMed Central 2010 2010-08-27 /pmc/articles/PMC2945068/ /pubmed/20799933 http://dx.doi.org/10.1186/ar3124 Text en Copyright ©2010 García-Arnandis et al.; licensee BioMed Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an open access article distributed under the terms of the Creative Commons Attribution License (http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Research Article
García-Arnandis, Isabel
Guillén, Maria Isabel
Gomar, Francisco
Pelletier, Jean-Pierre
Martel-Pelletier, Johanne
Alcaraz, Maria José
High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes
title High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes
title_full High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes
title_fullStr High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes
title_full_unstemmed High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes
title_short High mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes
title_sort high mobility group box 1 potentiates the pro-inflammatory effects of interleukin-1β in osteoarthritic synoviocytes
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2945068/
https://www.ncbi.nlm.nih.gov/pubmed/20799933
http://dx.doi.org/10.1186/ar3124
work_keys_str_mv AT garciaarnandisisabel highmobilitygroupbox1potentiatestheproinflammatoryeffectsofinterleukin1binosteoarthriticsynoviocytes
AT guillenmariaisabel highmobilitygroupbox1potentiatestheproinflammatoryeffectsofinterleukin1binosteoarthriticsynoviocytes
AT gomarfrancisco highmobilitygroupbox1potentiatestheproinflammatoryeffectsofinterleukin1binosteoarthriticsynoviocytes
AT pelletierjeanpierre highmobilitygroupbox1potentiatestheproinflammatoryeffectsofinterleukin1binosteoarthriticsynoviocytes
AT martelpelletierjohanne highmobilitygroupbox1potentiatestheproinflammatoryeffectsofinterleukin1binosteoarthriticsynoviocytes
AT alcarazmariajose highmobilitygroupbox1potentiatestheproinflammatoryeffectsofinterleukin1binosteoarthriticsynoviocytes